SPOTLIGHT: Targeted Genetics hits back against trial report

Targeted Genetics went on the attack after The Washington Post raised serious criticisms of a gene therapy trial that was suspended after the death of a volunteer. But Wired also notes that the company's response avoids many of the most serious criticisms leveled in the report. Report